We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEX
2926
DELISTED
Emerald Holding
EEX
$195K ﹤0.01%
36,235
-4,051
-10% -$21.7K
FTCI icon
2927
FTC Solar
FTCI
$45.4M
$191K ﹤0.01%
+1,432
New +$160K
ORMP icon
2928
Oramed Pharmaceuticals
ORMP
$180M
$187K ﹤0.01%
+13,982
New +$160K
EYPT icon
2929
EyePoint Inc
EYPT
$1.2B
$186K ﹤0.01%
+20,649
New +$198K
OYST
2930
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$183K ﹤0.01%
+10,651
New +$202K
AFIB
2931
DELISTED
Acutus Medical Inc
AFIB
$176K ﹤0.01%
+10,365
New +$152K
IMUX icon
2932
Immunic
IMUX
$205M
$174K ﹤0.01%
+1,416
New +$196K
FLL icon
2933
Full House Resorts
FLL
$88.5M
$171K ﹤0.01%
+17,172
New +$166K
CLNN icon
2934
Clene
CLNN
$68.4M
$169K ﹤0.01%
+752
New +$159K
TLMD
2935
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$168K ﹤0.01%
+29,530
New +$196K
FHTX icon
2936
Foghorn Therapeutics
FHTX
$360M
$167K ﹤0.01%
+15,659
New +$171K
FLNT
2937
Fluent
FLNT
$121M
$167K ﹤0.01%
9,523
-995
-9% -$19.6K
BMTX
2938
DELISTED
BM Technologies, Inc.
BMTX
$165K ﹤0.01%
13,267
+1,469
+12% +$17K
STR
2939
DELISTED
Sitio Royalties
STR
$164K ﹤0.01%
8,079
-4,434
-35% -$85.1K
NMTR
2940
DELISTED
9 Meters Biopharma
NMTR
$159K ﹤0.01%
+7,224
New +$177K
BYSI icon
2941
BeyondSpring
BYSI
$35.8M
$156K ﹤0.01%
14,945
+2,152
+17% +$22.7K
RMNI icon
2942
Rimini Street
RMNI
$471M
$155K ﹤0.01%
25,169
+7,309
+41% +$53.4K
VIA
2943
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$154K ﹤0.01%
2,725
-169
-6% -$9.02K
AVTX icon
2944
Avalo Therapeutics
AVTX
$980M
$151K ﹤0.01%
16
+7
+78% +$58.6K
RVP icon
2945
Retractable Technologies
RVP
$20.1M
$147K ﹤0.01%
12,685
+781
+7% +$8.21K
CSPR
2946
DELISTED
Casper Sleep Inc.
CSPR
$147K ﹤0.01%
17,805
-8,777
-33% -$76.6K
VRCA icon
2947
Verrica Pharmaceuticals
VRCA
$94.5M
$145K ﹤0.01%
1,284
-59
-4% -$7.15K
TLIS
2948
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$143K ﹤0.01%
+865
New +$147K
CRD.A icon
2949
Crawford & Co Class A
CRD.A
$658M
$142K ﹤0.01%
15,653
-1,450
-8% -$14.3K
URG
2950
Ur-Energy
URG
$552M
$138K ﹤0.01%
+98,602
New +$135K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.